Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025)
Alphatec Holdings (ATEC) posted Non-Current Deffered Revenue of $2.2 million for Q4 2025, down 30.37% sequentially from $3.1 million in Q4 2024, and down 30.37% YoY from $3.1 million in Q4 2024.
Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
Alphatec Holdings has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $2.2 million in Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 30.37% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 30.37% YoY) and the FY2025 annual result came in at $2.2 million, down 30.37% from the prior year.
- Non-Current Deffered Revenue slipped to $2.2 million in Q4 2025 per ATEC's latest filing, from $3.1 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $3.1 million in Q4 2024 and troughed at $2.2 million in Q4 2025.
- A 5-year average of $2.8 million and a median of $2.8 million in 2021 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue gained 20.42% in 2024, then plunged 30.37% in 2025.
- Over 5 years, Non-Current Deffered Revenue stood at $2.9 million in 2021, then grew by 3.45% to $3.0 million in 2022, then declined by 13.33% to $2.6 million in 2023, then gained by 20.42% to $3.1 million in 2024, then slumped by 30.37% to $2.2 million in 2025.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.2 million, $3.1 million, and $2.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Alphatec Holdings | 1.48 Bn | 1.36 Bn | 154.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 2.71 Mn |